Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


1 BMC Cancer
1 BMC Gastroenterol
1 BMC Surg
1 J Surg Oncol
2 Lancet

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. CHEN M, Jiang B, He B, Tang M, et al
    Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
    BMC Cancer. 2018;18:923.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  2. WANG D, Zhu H, Guo M, Fan X, et al
    Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma.
    BMC Gastroenterol. 2018;18:81.
    PubMed     Text format     Abstract available

    BMC Surg

  3. BAUSYS R, Bausys A, Maneikis K, Belogorceva V, et al
    Safety of expanded criteria for endoscopic resection of early gastric cancer in a Western cohort.
    BMC Surg. 2018;18:79.
    PubMed     Text format     Abstract available

    J Surg Oncol

  4. SUZUKI M, Yokobori T, Gombodorj N, Yashiro M, et al
    High stromal transforming growth factor beta-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25217.
    PubMed     Text format     Abstract available


  5. SMYTH EC, Petty RD
    Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma.
    Lancet. 2018;392:97-98.
    PubMed     Text format    

  6. SHITARA K, Ozguroglu M, Bang YJ, Di Bartolomeo M, et al
    Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
    Lancet. 2018;392:123-133.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.